Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Can J Physiol Pharmacol ; 91(1): 38-44, 2013 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-23368696

RESUMEN

Pulmonary arterial hypertension (PAH) induced by monocrotaline (MCT) is an experimental protocol of right heart failure. We analyzed the role of exercise training on the right ventricle structure and function, pulmonary artery remodeling, and GSK-3ß expression. Rats were divided among the following groups: sedentary control (SC), sedentary monocrotaline (SM), trained control (TC), and trained monocrotaline (TM). Rats underwent exercise training for a period of 5 weeks, with 3 weeks post-MCT injection. Rats in the SM and TM groups presented with an increase in right ventricle hypertrophy indexes and lung congestion. The right ventricular end diastolic pressure (RVEDP), right ventricular systolic pressure (RVSP), and its minimum and maximal pressure derivates were increased in the SM and TM groups. The right ventricle interstitial volume pulmonary artery thickness and p-GSK-3ß/GSK-3ß were increased in the MCT groups as compared with the control groups. The TM group had a reduction in interstitial volume, p-GSK-3ß/GSK-3ß ratio, pulmonary artery thickness, RVEDP, and an increase in intramyocardial vessels volume as compared with the SM group. The overall results have shown that the exercise protocol used promoted positive changes in right ventricle and pulmonary artery remodeling. These observations also suggest that structural remodeling may be influenced by signaling proteins, such as GSK-3ß.


Asunto(s)
Glucógeno Sintasa Quinasa 3/biosíntesis , Ventrículos Cardíacos/efectos de los fármacos , Monocrotalina/toxicidad , Condicionamiento Físico Animal/fisiología , Arteria Pulmonar/efectos de los fármacos , Función Ventricular Derecha/efectos de los fármacos , Animales , Glucógeno Sintasa Quinasa 3 beta , Ventrículos Cardíacos/enzimología , Ventrículos Cardíacos/patología , Hemodinámica/efectos de los fármacos , Hemodinámica/fisiología , Masculino , Arteria Pulmonar/enzimología , Arteria Pulmonar/patología , Ratas , Ratas Wistar , Función Ventricular Derecha/fisiología , Remodelación Ventricular/efectos de los fármacos , Remodelación Ventricular/fisiología
2.
Can J Physiol Pharmacol ; 90(8): 1095-103, 2012 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-22808939

RESUMEN

This study analyzed and compared the content of isoflavones in 2 soy products, the effectiveness of isoflavones as antioxidants, in vitro, and demonstrated the antioxidant effect of a soy diet in rats with myocardial infarction (MI). Isoflavone content was analyzed in soybean hypocotyl (SH) and isolated soy protein (ISP). The quality (TAR) and quantity (TRAP) of antioxidants present in the samples was quantified. The amount of daidzin was higher in SH (9 times) and genistein in ISP (5 times). SH presented a 3-fold increase in TAR, while both products exhibited same TRAP. The rats were fed an ISP diet for 9 weeks. Animals were distributed among 6 treatment groups: (i) Sham Casein; (ii) Infarct Casein < 25%; (iii) Infarct Casein > 25%; (iv) Sham Soy; (v) Infarct Soy < 25%; and (vi) Infarct Soy > 25%. MI was induced 5 weeks after the commencement of the diets. Lipid peroxidation (LPO), antioxidant enzyme activity, and levels of nitrites/nitrates were determined in blood. Rats receiving the ISP diet demonstrated increased activity of antioxidant enzyme activity and nitrite/nitrate content. In addition, the increase in LPO seen in rats subjected to MI was significantly mitigated when the ISP diet was given. These findings suggest a nutritional approach of using a soy-based diet for the prevention of oxidative-stress-related diseases such as heart failure.


Asunto(s)
Antioxidantes/farmacología , Isoflavonas/análisis , Isoflavonas/farmacología , Infarto del Miocardio/dietoterapia , Estrés Oxidativo/efectos de los fármacos , Proteínas de Soja/química , Proteínas de Soja/uso terapéutico , Animales , Biomarcadores/análisis , Biomarcadores/metabolismo , Modelos Animales de Enfermedad , Genisteína/análisis , Hemoglobinas/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Masculino , Infarto del Miocardio/sangre , Infarto del Miocardio/enzimología , Ratas , Ratas Wistar , Especies de Nitrógeno Reactivo/sangre
3.
Nutr Metab Cardiovasc Dis ; 19(2): 91-7, 2009 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-18571392

RESUMEN

We investigated the effects of an isolated soy protein (ISP) diet offered over a 9-week period to rats in whom myocardial infarction (MI) had been induced, and a casein diet given as a control. Male Wistar rats were assigned to six groups after infarct size determination (n=8/group): Sham Casein (SC); Infarct Casein <25% (IC<25%); Infarct Casein >25% (IC>25%); Sham Soy (SS); Infarct Soy <25% (IS<25%); and Infarct Soy >25% (IS>25%). MI surgery was performed at the fifth week, and one month later, the animals were hemodynamically assessed to evaluate left ventricular systolic pressure (LVSP), left ventricular end diastolic pressure (LVEDP), contractility and relaxation indexes (+/-dP/dt). Lung and liver specimens were also collected for the estimation of organ congestion. Oxidative stress was evaluated in heart homogenates through chemiluminescence (CL), carbonyl groups, and antioxidant enzyme activities of superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx). Infarcted groups treated with casein showed cardiac hypertrophy, lung and liver congestion, increased LVEDP and decreased LVSP and +/-dP/dt, all typical signals of heart failure. Ventricular dysfunction was correlated with increased myocardial oxidative damage as seen by CL and carbonyl groups data in the groups IC<25% and IC>25% (3 and 10-fold increase, respectively). The ISP diet was able to improve ventricular systolic and diastolic function in the groups IS<25% and IS>25% (LVEDP was reduced by 44% and 24%, respectively) and to decrease myocardial oxidative stress. The overall results confirm the preventive role of soy-derived products in terms of post-MI myocardial dysfunction probably by an antioxidant action.


Asunto(s)
Proteínas en la Dieta/administración & dosificación , Infarto del Miocardio/dietoterapia , Miocardio/metabolismo , Estrés Oxidativo , Proteínas de Soja/administración & dosificación , Disfunción Ventricular Izquierda/prevención & control , Función Ventricular Izquierda , Animales , Catalasa/metabolismo , Modelos Animales de Enfermedad , Glutatión Peroxidasa/metabolismo , Hígado/patología , Pulmón/patología , Masculino , Contracción Miocárdica , Infarto del Miocardio/complicaciones , Infarto del Miocardio/metabolismo , Infarto del Miocardio/fisiopatología , Miocardio/enzimología , Miocardio/patología , Carbonilación Proteica , Ratas , Ratas Wistar , Proteínas de Soja/aislamiento & purificación , Volumen Sistólico , Superóxido Dismutasa/metabolismo , Factores de Tiempo , Disfunción Ventricular Izquierda/etiología , Disfunción Ventricular Izquierda/metabolismo , Disfunción Ventricular Izquierda/fisiopatología , Presión Ventricular
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA